Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Kolehmainen S, Ylisaukko-Oja T, Jokelainen J, Koivusalo M, et al. Scand J Gastroenterol 2021 Jun 21:1-8. doi: 10.1080/00365521.2021.1938206.

Read + Share

Amedeo Smart

Independent Medical Education

Kolehmainen S, Ylisaukko-Oja T, Jokelainen J, Koivusalo M, et al. Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scand J Gastroenterol 2021 Jun 21:1-8. doi: 10.1080/00365521.2021.1938206.
PMID: 34154506